1. Call to Action to the Tech Community on New Machine Readable COVID-19 Dataset. The White House. https://www.whitehouse.gov/briefings-statements/call-action-tech-community-new-machine-readable-covid-19-dataset/. Accessed March 24, 2020.
2. ClinicalTrials.gov [Internet]. Bethesda (MD): National Library of Medicine (US). Identifier NCT03945825, Flublok or Fluzone With Advax-CpG55.2 or AF03; 2020 March 16 [cited 2020 March 23]; Available from: https://clinicaltrials.gov/ct2/show/NCT03945825?term=Advax&cond=influenza&rank=1.
3. Park A. AI develops’ turbocharged’ flu vaccine: A clinical trial will soon be underway in the U.S. to test the efficacy of an enhanced flu vaccine developed by an artificial intelligence system at Flinders University in South Australia. Becker’s Hospital Review. https://www.beckershospitalreview.com/artificial-intelligence/ai-develops-turbocharged-flu-vaccine.html. Accessed March 24, 2020.
4. Repurposing therapeutics for COVID-19: Supercomputer-based docking to the SARS-CoV-2 viral Spike Protein and viral spike protein-human ACE2 interface;Smith;ChemRxiv,2020
5. Reicher M. Coronavirus call centers stumble in Washington state: glitches, lack of staff, contradicting messages. The Seattle Times. https://www.seattletimes.com/seattle-news/times-watchdog/washington-coronavirus-hotlines-were-unprepared-for-onslaught-of-callers/. Published March 17, 2020. Accessed March 20, 2020.